Glucose Control In Hematopoetic Stem Cell Transplant

Summary

To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucose goal 110 mg/dl) using continuous IV insulin and glucose vs. non-intensive glucose management (goal 200 mg/dl)

Timeline

Start

2007-02

Primary completion

2009-05

Completion

2009-05

Drugs

Indications